C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 1/107 (2006.01) A61K 38/04 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07H 15/252 (2006.01) C07K 1/06 (2006.01) C07K 5/06 (2006.01) C07K 5/062 (2006.01) C07K 5/11 (2006.01) C07K 5/117 (2006.01) C07K 9/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2369933
The invention relates to a prodrug that is capable of being converted into a drug by the catalytic action of human fibroblast activation protein (FAP.alpha.), said prodrug having a cleavage site which is recognised by FAP.alpha., and said drug being cytotoxic or cytostatic under physiological conditions.
L'invention concerne un promédicament pouvant être converti en médicament par action catalytique de la protéine d'activation fibroblastique humaine (FAP.alpha.). Ledit promédicament comprend un site de restriction reconnu par la protéine FAP.alpha., et devient cytotoxique ou cytostatique dans des conditions physiologiques.
Firestone Raymond Armand
Garin-Chesa Pilar
Leipert Dietmar
Lenter Martin
Mack Jurgen
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Boehringer Ingelheim Pharma Kg
Fetherstonhaugh & Co.
LandOfFree
Fap-activated anti-tumor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fap-activated anti-tumor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fap-activated anti-tumor compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1994805